SCHEMBL30278759

SCHEMBL30278759

O=C(O)c1ccc(-n2nnnc2SCC(=O)N2CCc3cc(C(=O)O)ccc32)cc1

nearest known ligand 0.70

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 5/20 0.70
▸ APOBEC3A P31941 1/20 0.70
▸ APOBEC3G Q9HC16 1/20 0.70
▸ ALDH1A1 P00352 8/20 0.64
▸ LMNA P02545 2/20 0.60
▸ MAPK1 P28482 1/20 0.60
▸ ALOX15 P16050 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ HPGD P15428 1/20 0.52
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21952015 1.00 TSHR (0.70) TSHRAPOBEC3AAPOBEC3GALDH1A1LMNA
SCHEMBL21952051 0.94 TSHR (0.65) TSHRAPOBEC3AAPOBEC3GALDH1A1LMNA
SCHEMBL21951993 0.92 TSHR (0.65) TSHRAPOBEC3AAPOBEC3GALDH1A1LMNA
SCHEMBL21952017 0.92 TSHR (0.65) TSHRAPOBEC3AAPOBEC3GALDH1A1LMNA
SCHEMBL21952032 0.91 TSHR (0.63) TSHRAPOBEC3AAPOBEC3GALDH1A1LMNA
SCHEMBL22009411 0.90 TSHR (0.86) TSHRAPOBEC3AAPOBEC3GALDH1A1LMNA
SCHEMBL21952063 0.90 TSHR (0.62) TSHRAPOBEC3AAPOBEC3GALDH1A1LMNA
SCHEMBL21952024 0.89 TSHR (0.61) TSHRAPOBEC3AAPOBEC3GALDH1A1LMNA
SCHEMBL21952061 0.87 TSHR (0.61) TSHRAPOBEC3AAPOBEC3GALDH1A1LMNA
SCHEMBL30278739 0.87 TSHR (0.61) TSHRAPOBEC3AAPOBEC3GALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768422-B Ubiquitin ligase inhibitors for the treatment of cancer 诺沃亚桑托斯教授基金会 2025-03-04 — — CN disclosed
CN-115768422-A Ubiquitin ligase inhibitors for the treatment of cancer 诺沃亚桑托斯教授基金会 2023-03-07 — — CN disclosed
Send feedback